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Honourable Rector Magnificus, esteemed colleagues and guests,
It is a great honour and pleasure to be given the opportunity 
to address you for a second time from this rostrum. My 
first inaugural lecture, delivered some sixteen years ago, was 
about the What, How and Why of Clinical Decision Analysis. 
I explained that Clinical Decision Analysis is the academic 
discipline that concerns itself with describing, analysing and 
supporting medical decisions. Its aim is to improve both the 
process and outcomes of medical choices. Because healthcare 
nearly always involves making choices under uncertainty, 
clinical decision analysis proceeds from the principle of 
maximizing ‘Expected Utility’: i.e. the sum of numerical 
products, obtained by multiplying all relevant probabilities 
and outcomes, supported by the best available evidence. This 
approach has brought us many benefits and still underpins 
decision making and policy making in many fields of medicine, 
ranging from guideline development to care-package choices. 
But there is more. After choice comes care execution and this, 
likewise, determines health outcomes. 
In November 1999, the Institute of Medicine published the 
report ‘To Err is Human’. This report described how patients 
die not only in spite of, but - sometimes - as a consequence 
of, the efforts of healthcare workers. Patients may die from 
hospital infections, blood transfusions, medication errors, 
complications, identity- or procedural mix-ups etc. According 
to a report published in 2007 by EMGO-NIVEL entitled 
‘Unintended Harm in Dutch Hospitals’, such errors also 
occur in the Netherlands.1 The authors estimated that there 
are approximately 1735 avoidable deaths per year: 0.13% of 
all admissions. A follow-up investigation in 2010 showed 
that it would take more than a couple of years to reduce the 
incidence of unintended harm.2 The underlying causes are 
far too complex and involve too many different factors. What 
such investigations dramatically demonstrate, is that good 
healthcare is more than just finding the right answer to the 
question: ‘What is the best treatment choice?’. It is equally 
important to delineate the best mode of performance: ‘What is 
the best possible treatment execution? 
Standards and Definitions for high quality care
Over the years, a stratified system of layers of standards 
has come into existence to give guidance to healthcare 
professionals on how to provide the best possible care.
The first and most fundamental layer is that of Medical 
Ethics: the intrinsic moral motivation to do good to our 
patients. A motivation that was put in writing over two 
thousand years ago in the Hippocratic oath. Moral standards 
apply not just to doctors but likewise to other care providers, 
and require all to - 1) respect patient autonomy, 2) do no 
harm, 3) do good and 4) be fair. I apologize for the fact that 
when I talk about doctors later in my address, I present them 
as an example of healthcare providers in general. I do so 
because my knowledge and understanding of being a doctor is 
greater than of the practice of other healthcare professions. 
The second layer consists of standards installed by professional 
bodies such as the Royal Dutch Medical Association (KNMG), 
guideline committees and other professional organisations. 
These standards are not just concerned with general principles, 
such as those of the seven competences of the ‘Canadian 
Medical Education Directives for Specialists’ (CanMeds).3 
They are also about more specific standards, for example, 
Standardization Surgical Treatments 3.0, published in June 
2012 by the Association of Surgeons of the Netherlands.
The third layer refers to the legal framework that sets out 
what can be expected from a good healthcare practitioner. 
The foundation is the Government Act for Professions 
in Healthcare for Individuals (Wet op de Beroepen in de 
Individuele Gezondheidszorg - Wet BIG). This states that 
healthcare providers, ‘organise their work and have access to 
the necessary equipment to carry out their profession in such 
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a way that there is a reasonable expectation that this will lead 
to responsible provision of care’. This also entails ‘systemic 
monitoring, control and improvement of the quality of care’. 
Other such laws include the Medical Treatment Contracts 
Act (Wet op de Geneeskundige BehandelingsOvereenkomst 
- WGBO) and the Quality of Healthcare Institutions Act 
(KwaliteitsWet Zorginstellingen - KWZ).
Finally the fourth and most recent layer is that of 
measurement of healthcare quality by means of indicators. 
According to the definition given by the ‘Transparent Care 
in Hospitals’-project (Zichtbare Zorg Ziekenhuizen - ZZZ), 
indicators are, ‘measureable aspects of care provision that can 
give an indication of the quality of care’. These indicators are 
used in several ways. Firstly, to allow healthcare professionals 
or institutions to monitor, control and improve their own 
quality of care (see the BIG-Act requirement mentioned 
above). This is referred to as the ‘internal use’ of quality 
indicators. There is also an ‘external use’. For example, to judge 
whether the level of care is in keeping with the levels expected 
by society. Or to offer information that allows patients and 
health insurers to choose the most suitable care provider. 
So what does Quality of Care actually mean? Let us look at a 
few definitions. The Institute of Medicine (IOM) (in 1990) 
defined Quality of Care (QoC): ‘the degree to which health 
services for individuals and populations increase the likelihood 
of desired health outcomes and are consistent with current 
professional knowledge’. The Agency for Healthcare Research 
and Quality (AHRQ) (in 2003) gave an even more succinct 
definition: ‘doing the right thing at the right time in the right 
way for the right person and having the best results possible’. The 
above definitions may be conceptually coherent but they are 
too general for practical application. This is why, in practice, 
Quality of Care is divided into a number of dimensions. The 
most common are: 1) Safety, 2) Effectiveness, 3) Efficiency, 4) 
Patient Centeredness, 5) Timeliness and 6) Equity.
Uncertainty
Why not just make everything simpler? If the patient’s health 
improves - care is good; If the patient’s health deteriorates - 
care is bad. 
The problem is that medicine is about probabilities. The 
probability that, even without any medical interventions, 
changes in health states will occur spontaneously in 
patients, sometimes for the better, sometimes for the worse. 
This ‘probabilistic nature’ of medicine has far reaching 
consequences. Such as the fact that a diagnostic test does not 
always tell the truth, or the whole truth. Tests may be false 
positive and induce unnecessary anxiety in patients. On other 
occasions negative test results may give false sense of security, 
whereas in reality the test was not sensitive enough, or was 
simply not the appropriate test. Contrary to what we would 
all like to believe, no diagnostic test is a 100% reliable. This is 
not because someone did something wrong or got it wrong. 
It is because a test is not always able to detect what we need 
to know, and in other cases may not be able to discriminate 
between normal variation and pathological changes. These test 
limitations are common knowledge in science, quantified by 
the concepts sensitivity and specificity. 
These test shortcomings are the reason that it is ill-advised 
for a healthy person to undergo a ‘total body scan’. Slight 
abnormalities on such a scan may instigate expensive and often 
burdensome follow-up tests, with the risk of unintended harm 
before the anxious person can be given the all clear. Moreover, 
a ‘clean’ scan does not give any guarantees - it is still possible 
to develop acute leukaemia or have a heart attack shortly after. 
It is for these reasons that the ‘total body scan’ is not offered in 
the Netherlands, and that those who are determined to have 
one must go elsewhere. This is why the company that ran an 
advertising campaign with Dutch celebrities banging the drum 
for the benefits of the scan was found guilty of misleading the 
public.4  
Let us look at a few facts and figures about diagnostics. 
The utility of breast-cancer screening has been debated for 
decades. Recently, an independent panel of experts, chaired by 
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Professor Sir Michael Marmot (University College London, 
Epidemiology and Public Health), concluded that routine 
breast cancer screening reduces the risk of dying from breast 
cancer, but also results in over diagnosis.5 Their conclusions, 
published in The Lancet in 2012, exemplify that for each 
breast-cancer death prevented, three women will suffer 
the anxiety and physical burden of undergoing treatment 
for breast cancer unnecessarily.6 Unnecessary, not because 
someone got it wrong or made a mistake, but because, if they 
had not been screened, the microscopic cancerous changes in 
the breast would have gone unnoticed and these women would 
have died in old age of other causes. The problem is we do not 
know enough to distinguish between the one woman who will 
benefit from treatment and the three who will be put through 
unnecessary treatment. Prostate cancer screening is even more 
disappointing in terms of health cost-benefit. A Cochrane 
review, updated in 2011 and 2013, concluded that prostate 
cancer screening does result in more cancer diagnoses and 
treatments, but does not reduce prostate cancer mortality (for 
a relative risk of death of 1.00 at 10 years).7  
The probabilistic nature of medicine care not only complicates 
diagnostic testing, but also judgements about medical 
treatments. Every treatment, even carried out absolutely 
correctly, involves some kind of risk. To confuse matters even 
more, it is entirely possible that, after a completely ineffective 
treatment, patients can improve of their own accord - just 
because nature takes its course. This is why those working in 
medicine will, unlike the media, not draw conclusions based 
on a single case. Instead, policies and guidelines are based on 
rigorously constructed and meticulously carried out studies in 
sufficiently large patient groups. And this is why in medicine - 
‘Something turned out wrong’ does not mean that ‘Somebody 
did something wrong’. 
The Dutch Healthcare System
In clinical practice and during medical training, we are 
accustomed to take a critical yet positive approach and ask 
ourselves: ‘What went well? What could be improved?’ Well, 
we can safely say that the Dutch Healthcare system got, and 
gets, a great deal right most of the time. This is convincingly 
demonstrated by the European Health Consumer Index 
(EHCI), a healthcare assessment system that is run by an 
independent organisation from Stockholm in association 
with the European Commission.8 The EHCI measures 
how European citizens rate their healthcare systems by 
means of detailed and absolutely transparent system of 42 
indicators ranging across five sub-disciplines. In the EHCI, 
the Netherlands has not only been in the top three since 2005 
but has irrefutably held first place for three consecutive years: 
in 2010, 2011, and again in 2012. The press release - Brussels 
2012 - states ‘The Index champion was the Netherlands, gaining 
872 out of potential 1000 points … The Netherlands should set 
the standard for European healthcare reform ... Their healthcare 
seems able to deal with new conditions and delivers top results’.9 
In the light of the outstanding performance of the Dutch 
Healthcare system, it would be better for the motivation of 
health professionals as well as to instil confidence and trust in 
patients and consumers, if the media gave this achievement the 
attention it deserves. 
However, there are certainly areas in Dutch healthcare that 
can be improved, in particular with respect to: 1) healthcare 
outcomes and patient experience, and 2) the spiralling cost of 
healthcare provision. And there is another problem - and that 
is how we interpret and deal with these two areas. 
Issues are nearly always more complex than they appear, for 
instance, because one determinant may have many outcomes 
and one outcome may have more than one determinants. 
In public debate, certainly in political discourse, people 
and parties tend to underplay their own contribution to a 
problem while overemphasising their contribution to its 
solution. ‘Mistakes were made but not by me’, is the title of 
an insightful book about this phenomenon.10 The irony of 
advertising slogans that advocate their own products, allegedly 
without bias, is also apparent in public debates, for example, 
in June 2013 when lobbies in the field all presented their own 
‘solutions’ to the Minister of Health as the best way to cut 
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costs. An ‘Us versus Them’-attitude is fatally flawed, because 
every party in the healthcare system can at some point 
contribute to the cause of a problem. 
I will now discuss the roles of the various parties in order: the 
patient, the professional healthcare provider, the healthcare 
insurer and the government.
The patient
The first party we will look at is the patient seeking help to 
solve his health problem. A patient knows better than anyone 
how serious this problem is and how much impact it has on 
his life. In an ideal world, during the first consultation the 
patient and physician will discuss the gravity of the health 
problem, any other health issues (so-called co-morbidity), 
and expectations for recovery. This last element requires the 
diagnostic and prognostic expertise of a trained physician. The 
combination of the current health problem and of its expected 
future course is often referred to as the ‘burden of disease’: the 
observed and expected loss of health, either because of reduced 
life-expectancy or of reduced quality of life, over the years lived 
with the health condition. During consultation, this burden of 
disease, in combination with the opportunities and limitations 
of diagnosis and treatment, will be discussed in making plans 
for further action.
This is the ideal scenario but, unfortunately, this is not always 
what happens. Exchanging information takes time. If there is 
not enough time available because of work pressure or because 
consultation time is not eligible for payment, the process is 
often hurried and simplified. The physician may be quick 
to present a treatment plan that may or may not have been 
preceded by a thorough diagnosis. 
The patient, also facing time pressure, may accept a treatment 
plan without due consideration of pros and cons, perhaps 
assuming that, “The doctor wouldn’t offer me a treatment if 
it wasn’t the right one?”. Standard disclosures summarising of 
risks and benefits may be ineffective, “The doctor told me that 
there was only a few per cent risk; so it would be very unlucky 
if it happened to me”. And thus, time pressures and inadequate 
consideration result in a treatment plan that is not fit for 
purpose; a plan about which the patient is too optimistic and is 
likely to be disappointed by its outcome. 
Moreover, it is not always the case that patients are more 
reticent than their physicians. Sometimes patients will demand 
an X-ray, a new treatment, a popular diagnostic screening 
test (Prostate Specific Antigen - PSA), or even a total body 
scan, even though there are no medical reasons to do so. 
This can be because they over-rate the diagnostic power of 
tests, or misunderstand and under-rate the complexity of 
probability issues, or just because they believe they are entitled 
to such a procedure. One relevant phenomenon is misplaced 
optimism. Crites and Codish recently published a study on 
participation in Phase -1 trials in the Journal of Medical 
Ethics. They described how parents remained convinced 
that their child would be the one to benefit above average 
from participating in a trial, even though the evidence to the 
contrary was fully explained to them.11 The authors warned 
that unrealistic optimism - making important decisions 
on the basis of delusion - is not the unassailable right of 
autonomous patients, but may actually impair their autonomy. 
Unrealistic optimism plays a more significant role the bleaker 
the prognosis, for example concerning care at the end of life. 
The extent and degree of unintended and unnecessary harm 
caused to patients in such situations was discussed at length 
during the Care Package Debate of the Healthcare Insurance 
Board (College voor Zorgverzekeringen - CVZ) in 2012, as well 
as during the symposium ‘Never give up’ of the Royal Dutch 
Medical Association (Koninklijke Nederlandse Maatschappij 
ter bevordering van de Geneeskunst - KNMG). An illustration 
of how far both patient and doctor can be led by false hope 
was succinctly put in a publication by Anne-Mei The in the 
British Medical Journal (2000): ‘The physician did not want to 
pronounce a ‘death sentence’ and the patient did not want to hear 
it’.12  
To sum up, poorly informed patients and patients in great 
distress are easily seduced by optimistic options. This leads to 
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both excessive use of healthcare and unnecessary costs, both of 
which amount to an ultimate ‘Lose-Lose’-situation.
The Healthcare Provider
The second party is the care provider - often a doctor. This 
doctor must do the right thing and also do it the right way. 
Here, again, the ‘What?’- and ‘How?’-questions come into play. 
Let’s first deal with the ‘What?’ 
In an ideal world the physician will provide appropriate care 
that is fit for purpose. However, this is not always the case and 
there are a number of reasons for this. 
The first and probably most important reason is that incentives 
in the healthcare system are erroneously aligned. Many reports 
have highlighted this problem, including that of former 
Minister of Health, Ab Klink, and BOOZ-Consultancy.13 What 
this boils down to is that if you reward procedures, you will get 
procedures. 
The second reason is that complex choices need to be made, 
especially for frail elderly patients or those with a combination 
of disorders (so-called multi-morbidity). Because ‘super’ 
specialised physicians are associated with excellence, they 
may seem to be the best choice but this tends to result 
in fragmented care. The danger is that super specialists 
(inevitably) tend to focus on their particular area of expertise. 
In doing so they may overlook wider issues and forget to weigh 
up how a patient’s overall quality of life can be negatively 
affected by a specific medical treatment. If a more careful and 
holistic approach would be taken, and more questions were 
asked about the patient’s overall situation, this would result in 
fewer treatments, without health loss but rather with overall 
health gain. 
The third reason that an appropriate care regime is not always 
applied is, perhaps surprisingly, ‘innovation’. Innovation 
has brought much that is good. In endocrine surgery, the 
laparoscopic adrenalectomy is a perfect example. No longer, 
as in the past, is a sizeable incision necessary that cuts through 
layers of abdominal and thoracic muscle, sometimes involving 
dissection/detachment of the diaphragm. The offending 
adrenal gland can now be removed via a few tiny holes in the 
abdomen. However, advances made in minimally invasive 
procedures, exploratory laparotomies and robot surgery can 
also have unforeseen consequences, as described in a report 
published in 2011 by the Dutch Healthcare Insurance Board 
on Robot Assisted Radical Prostatectomy (RARP).14 The 
report shows that, in the competitive arena of modern Dutch 
healthcare, hospitals are more likely to buy their own expensive 
equipment, such as a state-of-the-art Da Vinci Robot, for fear 
of losing patients to their competitors. However, once this 
expensive robot has been purchased, it has to provide adequate 
return on investment. As a consequence, more procedures may 
be carried out for economic or volume-reasons, instead of 
because of what is good for the patient. The report concludes, 
‘This can lead to over application of Robot Assisted Radical 
Prostatectomy (RARP) that may not be beneficial for all patients 
… Over use of medical innovations ... not only pushes up the 
costs of the Healthcare System, but also stand in the way of the 
optimal distribution of collective resources’. 
After dealing with the ‘What?’ now we arrive at the ‘How?’-
question. 
Newspapers regularly report that hospitals or doctors do 
not always achieve equally good results. This can be caused 
by variations in patient mix, or in the complexity of care 
provided. Much is known about differences in death rate 
following highly-complex, low-volume interventions, such 
as oesophageal-, aortic or pancreatic surgery. Likewise, much 
is known about variations in the quality of care for cancer 
patients, as was demonstrated in a report by the Signalling 
Committee on Cancer (Signalerings Commissie Kanker 
- SCK) that was published by the Dutch Cancer Society 
(KWF Kankerbestrijding) in 2010. This report is particularly 
undisputed because the information it contains was actually 
collected with, and collated by, healthcare professionals 
themselves. In this context I must mention the outstanding 
achievements of the SKC Chair, my surgical colleague 
Cornelius Van de Velde, whose 25th anniversary as professor 
was celebrated yesterday with the award of the Order of the 
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Netherlands Lion. 
Various studies, both international and national, argue there 
are advantages in appropriately concentrating care. This is 
particularly the case if the concentration of care is combined 
with the measurement of outcomes. My surgical colleague, 
Michel Wouters, who defended his PhD thesis here last week, 
described this in a study in 2010 for which he won the IQ-
award for the best paper on how to improve quality of care in 
the healthcare system. 
The pace at which improvements are now being made is 
impressive. Unfortunately, this also demonstrates that care 
providers did not always have their house in order.
The Healthcare Insurer
The third party is the Healthcare insurer who judges and 
purchases healthcare on the basis of external quality indicators, 
in accordance with regulations set down by law. However there 
are some observations to be made with respect to both the 
quality of the indicators themselves, as well as with respect to 
the way they are used. 
In 2012, the Netherlands Federation of University Medical 
Centres (NFU) published the report ‘Limited Visibility’ 
(‘Beperkt Zicht’); a combined effort by University Medical 
Centres in Amsterdam, Rotterdam and Leiden, and funded by 
the government.15 The report concluded that the information 
provided by hospitals to build two important indicators 
sets (‘Breast cancer’ and ‘Hip or knee replacement’) was not 
really reliable. The main reasons for this are that definitions 
are insufficiently clear or practical, and that there are huge 
differences between hospitals with respect to the methods of 
data registration, data access and self-assessment. 
The report also notes that the combination of external 
pressures and self-evaluations can lead to socially desirable 
answers. For example, in response to a question on the 
percentage of patients who received prophylactic antibiotics 
within 15-60 minutes prior to the start of surgery, the 
astonishing answer of some hospitals was, “100%, according 
to protocol” - and yet no one there checked to see if such a 
perfect score was really true. Hospitals that did investigate 
what really happened and gave an honest, reliable but less 
than perfect answer were not rewarded - quite the opposite. 
They had to defend themselves and explain why they did 
not achieve the 100% that their less scrupulous colleagues 
reported. That the combination of absolute transparency and 
punitive intolerance can lead to extremely serious situations, 
is illustrated by two recent stories concerning in the National 
Health Service (NHS); the centralised and closely monitored 
healthcare system of the United Kingdom, that we often hold 
up as an example.
In the NHS, Accident & Emergency waiting times have been, 
and still are, as much an issue as they are in the Netherlands. 
The Labour Government took decisive action in 2004 and 
announced that not a single patient should have to wait for 
more than four hours in an A&E department. This demand 
was later reduced to a 98%-norm, but was still rigorously 
enforced, with huge fines, lower payments and dismissal of the 
managers responsible.16  
The rigorous adherence to a four-hour deadline for 98% 
of patients - the combination of absolute transparency 
and punitive intolerance - led to increased staffing and to a 
dramatic reduction in reported waiting times. However, this 
approach of ‘targets and terror’ also had unintended negative 
consequences. Reports began to appear in the British media 
about the emergence of strategic behaviour: ambulances 
were not allowed to bring in patients if there were already too 
many patients waiting, and were urged to wait in the hospital 
car park until it was less busy in A&E.17 Others reported that 
patients were being prioritized on the basis of how near they 
were to the four-hour deadline, instead of on the basis of 
clinical urgency. Sometimes patients were no longer seen as 
urgent because they had been waiting for longer than the four-
hour deadline anyway. Other patients were swiftly transferred 
to other departments without a proper diagnosis, were 
admitted hastily and had to lie in soiled beds because there 
were no clean beds available. 
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A recent NHS-scandal concerns the Mid Staffordshire 
General Hospital in the West Midlands, which was the subject 
of a major inquiry chaired by Sir Robert Francis.18 The figures 
seemed to suggest that performance targets were being met 
and that everything was going swimmingly. However, repeated 
complaints by a determined group of ex-patients and their 
family members together with reports of an excessively high 
HSMR (Hospital Standardised Mortality Ratio) led to calls 
for further investigation. The hearing that preceded the 
Francis Report revealed some shocking insights: ‘Staff told 
the Healthcare Commission that there was “pressure, pressure, 
pressure” on them to meet the four-hour A&E waiting time 
target. Several doctors recounted occasions where managers had 
asked them to leave seriously ill patients to treat minor ailments 
so the target could be met. One gave an example of being asked to 
leave a heart attack patient being given life-saving treatment’.19 
Management and staff were very much aware of performance 
indicators. In fact, so much so that the numbers ceased to be 
perceived as a means to improve but became the goal in itself; a 
goal that led to the debasement of essential moral standards of 
healthcare. Figures became more important than patients and 
this resulted in patients not being treated with respect, being 
ignored, neglected and left lying in their own filth. In spite 
of a glowing report of achieved indicators, the evidence also 
showed that poor care had led to an estimated 400 unnecessary 
deaths.20 Paradoxically, the indicators HMSR and the SMR 
contributed to uncovering the extent of the indicator-related 
problem.
The lesson learned is that indicators are not intrinsically bad 
or good in healthcare. Rather, it all depends on how reliable 
they are, on the way they are implemented, the way they are 
enforced and on how punishments are imposed. The most 
negative effect of absolute transparency combined with 
punitive intolerance is that indicators tend to supplant the 
other three motivation levels of medical ethics, professional 
standards and the law. It is precisely that corruption of moral 
standards that leads to disaster.
The Government
Earlier on I described how well our healthcare system scores 
in comparison to other European countries. This has come 
at a high price, with Dutch healthcare costs doubling from 
45 billion euros in 2000 to 90 billion euros in 2011. Costs for 
basic health are funded via a system of compulsory insurance 
combined with compulsory acceptance, for which all Dutch 
citizens must pay contributions. This means that our economy, 
or rather that of our children and grandchildren, is in danger 
of collapsing under the burden of healthcare expenditures. To 
keep costs down, the Healthcare Insurance Board uses four 
‘care package-criteria’ to manage what is (or is not) included 
in the basic healthcare package: necessity, effectiveness, cost-
effectiveness and feasibility.21 The facts show that the adding 
a treatment to the basic healthcare package rarely leads to 
disgruntled citizens, whereas a negative package-decision can 
meet with protests. This is particularly the case for innovative 
treatments, for which a system of provisional acceptance has 
been in place since January 2012. Provisional acceptance is 
linked to the stipulation that within a period of four years the 
care provider in question must submit information about the 
effectiveness and cost-effectiveness of the particular treatment, 
to underpin the final decision. However, the Achilles heel of 
this system is that if the data are incomplete or of poor quality, 
no clear conclusions can be drawn about effectiveness. As a 
result, unproven care can linger in the basic healthcare package 
indefinitely, because no one wants to burn their fingers trying 
to oust a treatment. This situation invites manipulation: 
if a medical product is of dubious quality, providers may 
purposely deliver inadequate data as this is more likely to keep 
the product in the basic healthcare package than submitting 
accurate data. 
Costs increase not just because of forces in the workplace. They 
also increase because there is a great deal of confusion related 
to the societal framework within which care is delivered. If 
governments remain hesitant about addressing the limits of 
this framework, this will inevitably contribute to escalating 
costs.
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From Good to Better
I now come to the last part of my argument where I will 
talk about how to improve healthcare outcomes and patient 
experience, how to manage the spiralling cost of healthcare, 
and about ways to interpret and deal with these problems. I 
mentioned earlier that there is rarely a simple solution to a 
complex problem. It is not uncommon for solutions to induce 
new, other, secondary problems. This is sometimes called the 
Law of Conservation of Misery, or in ‘Johan Cruijff-speak’: 
“every advantage has its disadvantages”. With a bit of luck, the 
disadvantages are minor. But, if you are not so lucky, they may 
be even more detrimental than the original problem. There 
is a tendency to ignore such secondary problems, because 
of complacency, ideology or political motives, or maybe just 
because of unrealistic optimism. However, in the long run, it 
is far wiser to give these secondary problems careful attention 
and devise appropriate secondary solutions. A planned strategy 
will benefit from it, or else be renounced, and rightly so. 
Improving healthcare outcomes and patients’ experiences 
starts by making the right choices in the doctor’s consulting 
room. How this should be done is described in ’The Salzburg 
Statement on Shared Decision Making’.22 This declaration was 
drawn up and countersigned by 58 experts from 18 countries, 
including my colleague professor Anne Stiggelbout. The 
declaration stipulates that important decisions should always 
be made together with the patient, and it provides guidelines 
on how best to converse with patients about, for example, 
personal preferences and about risk. In 2013, this declaration 
was also signed by the LUMC’s Chairman of the Board. We, 
as healthcare professionals at the LUMC, must put these 
principles into practice, and will need to ask our patients - not 
just ourselves - to judge whether we are successful in doing so. 
The Department of Medical Decision Making carries out 
a great deal of solid research in cooperation with various 
clinical Departments. For example, research is being carried 
out to find out which outcomes are more important or less 
important to colon cancer patients. Other research explores 
how breast cancer patients and their physicians deal with risk, 
and how they deal with risk-uncertainty in specific situations. 
Again other research projects explore how different treatment 
processes and healthcare outcomes can be weighed up, and 
how this knowledge can be used in our search for the best 
decision. In doing this we have to take into account more than 
health alone in order to make a broad estimation of ‘subjective 
well-being’. New research is being initiated and financed within 
the framework of the research profiling area ‘Innovation and 
Quality of Health’. Among other topics, it focuses on Michael 
Porter’s concept of ‘Value based Healthcare’: a clever ‘rotation’-
adaptation of the concept of ‘Cost per Quality Adjusted Life 
Year’ to the far more marketable concept of ‘Value for Money’.23 
Our goal is to firm up this concept by supporting it with clear 
and clinically applicable frames of reference. Cooperation with 
the ‘Decision Laboratory’ in Cardiff has proved exceptionally 
fruitful. 
In practice, however, an important drawback of Shared 
Decision Making is that it requires a great deal of one of our 
most precious commodities: time. This means increased 
pressure on surgeries and consultations, not just within 
the LUMC, but for all healthcare providers. To my mind 
this presents a fantastic opportunity to install a form of 
coordination between healthcare professionals at a local and 
national level. How beneficial it would be for both patients 
and doctors, if we had a National Healthcare website that can 
deliver decision support, by providing high-quality scientific 
information in accessible language on diseases, symptoms, 
prognoses and co-morbidity, as well as on the pros and 
cons of diagnostics tests and specific treatments. Patients 
could visit this site to find out under which circumstances 
a particular choice is good or not so good, and to find out 
which important questions to ask their doctors. A National 
Healthcare website that is easy to navigate and in a welcoming 
and reassuring format. Wouldn’t it be wonderful if this 
website were supported by all parties that signed the Covenant 
for Appropriate use of Care in 2011, including the Health 
Care Insurance Board, the Netherlands Organisation for 
Health Research and Development (ZONMW), KPMG, the 
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Federation of Patients and Consumer Organisations in the 
Netherlands (NPCF), Dutch Health Insurers (ZN) and the 
Order of Medical Specialists (OMS), and by ZONMW and 
OMS in their ‘Campaign for Responsible Choices’. What a 
tremendous opportunity for our new national Institute for 
Quality of Care, which has the ambition to bring together 
and assist all the players in the field! How likely it is that the 
millions invested to build and maintain such a website will 
bring huge returns and advantages! That such a website has 
not yet been built is actually astonishing. A little less market 
competition and a little more cooperation between parties is, 
to my mind, the perfect ‘litmus test’ to determine, in actions 
not words, whether the patient truly is at the centre. 
Better healthcare - as you will realise by now - is not just a 
matter of better choices but also of better care-execution. 
A necessary condition is that the healthcare professionals 
themselves are absolutely committed to excellence through 
disciplined attention to detail, such as preventing infections. 
Moreover, that we improve ways to scrutinize each other. A 
positive and open working climate does not exclude rigorous 
professional discipline. In fact, through a shared sense of 
professional pride that ‘we did a really good job’, these two 
aspects can actually reinforce each other. Leading American 
hospitals have shown just how effective strict infection 
prevention can be and how many prosthesis- and other 
catastrophic infections can be avoided. It is our intention to 
achieve similar improvements in the LUMC with the aid of our 
international contacts through Dr Foster Global Comparators. 
Undoubtedly more hospitals will want to do this. 
Better healthcare requires putting better structures and 
processes in place. This is why work processes at the LUMC 
are now being organised via care pathways and LEAN 
management in order to centre care on the patient instead 
of the other way around, and are being equipped with all the 
right checks and balances. Some of these processes will be 
supported, in future, by logistics and operations research, for 
which our collaboration with the Technical Universities of 
Delft and Twente are of great value.
Improve and Change
There is more to change and improvement than just sending 
out a memo and waiting to see how much is left after it has 
trickled down the LUMC management lines. Good and 
professionally supported change management is required, 
with absolute clarity regarding urgency, ambition, planning, 
leadership and interaction.24 The outstanding expertise at the 
LUMC in implementation and implementation research, as 
evidenced by many successful grants, will be of great service. 
Internal change also requires optimal access to a local 
intranet. As a low-threshold mode to exchange data, intranet 
encourages internal candour and so increases the odds for 
healthcare improvement. It is good news that now - after much 
grumbling over the years - the intranet is receiving serious 
attention. 
Many improvement initiatives are planned, fine-tuned, 
initiated, made concrete and monitored in our LUMC-
wide ‘Healthcare Reform Programme’. The support and 
commitment of all who work in the organisation - from 
project leaders to those on the work floor, from staff councils 
to the Board of Directors - is remarkable and impressive. 
But initiating change is not enough - it must be carried 
through and tested within a water tight Plan-Do-Check-Act 
cycle, of which the last two often prove to be so troublesome. 
Healthcare reform and care improvements demand enormous 
effort so cost money in the short term. However, in the 
long term, healthcare improvements also save money by 
increasing efficiency, avoiding mistakes that are costly to 
rectify and reducing complications. But we must be realistic 
and acknowledge that improved healthcare may also be more 
expensive in the long term as well as the short term, because 
of investment in state-of-the-art equipment or because of 
more effective but expensive medications. Here also, nationally 
as well as locally, the principle of cost-effectiveness must 
determine choices, so that all patients get the most health 
benefits per health-care Euro spent. 
Monitoring healthcare reform and quality of care 
improvements requires us to know exactly how patients benefit 
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and how patients experience care. That we know risks, so that 
we can manage them appropriately. This is why, for decades, 
the LUMC has put in considerable effort, both locally and 
nationally, to report and register complications and incidents. 
With the most recent instrument - the EZIS Complications 
Suite - as a shining example of internal feedback. From such 
data, for example, we know that mortality rates on the surgical 
department have been halved in ten years - a magnificent 
result. 
However, patients do not primarily come to us to avoid 
complications but to get something, namely a solution to their 
health problem. This is why we need to know more than just 
incident and complication rates. Therefore, over the last year 
a LUMC-wide set of performance indicators was designed, 
that aims to provide professionals and management with the 
information they need to monitor and improve the quality 
of their care. Low threshold-feedback from our patients, 
about the care they received, including their suggestions for 
improvement, is a crucial element in this design. This provides 
patients with the voice that will truly put the ‘patient at the 
centre’. The need for such information is urgent, as clinicians 
are in need of reliable steering information. Healthcare 
professionals want to move forward, not later but now, and 
they want to do this on the basis of accurate information. 
This requires clear and decisive choices in weighing up the 
balance between the ‘value triangle’ of speed, quality and cost 
of implementation.
Honourable audience, there is far more excellent work going 
on. But appropriate use of time for my inaugural lecture 
means I am not going to tell you about other outstanding 
multi-disciplinary initiatives in the fields of: self-management, 
care and rehabilitation for the elderly, about the Dutch 
Federation of Universities Quality of Health, Dr Foster Global 
Comparators and other exciting projects. But before I end, let 
me make one final point.
Management
I would like to highlight two management theories: Theory 
X and Theory Y.25 The managers among you will know these. 
Theory X starts from the premise that workers are lazy and 
unmotivated. They must be pressured to work, and watched 
over at all times via a hierarchical structure and externally 
imposed indicators. In contrast, Theory Y starts from the 
assumption that professionals are intrinsically motivated 
to do their work to the best of their ability; that they derive 
pleasure from their work, are creative and monitor and correct 
themselves. 
Briefly, Theory X aims at combatting poor performance while 
Theory Y aims to encourage ‘good to become excellent’. Reflect, 
and decide whether you did your best work through ambition 
or through fear of reprisals. 
 The effect of ‘Theory X to the extreme’ is illustrated by the 
two recent examples from the NHS, where managers and 
professionals were so obsessed that they forgot basic ethical 
norms and values, worshipped the stats and neglected their 
patients. This would be a disastrous path. Not just because our 
highly rated health-care system does not deserve this, but also 
because it is counterproductive. The failings and mistakes made 
in our Education System in this respect seem to have been 
forgotten. Does our Healthcare System have to retrace these 
steps to discover this? In addition, implementing Theory X and 
asking for accurate self-reporting testifies to naïve expectations. 
What are the chances that a below par professional will register 
his or her poor performance accurately? If you so want to 
detect failings via this route, then be consistent and take the 
responsibility of quality reporting away from the healthcare 
professionals. For example, by extracting information directly 
from digital clinical care data to deduce whether indicators are 
being met, and perhaps by employing independent registration 
experts. Healthcare professionals will thank you for it. This 
will not only free up valuable time for patient care, it will 
also prevent those who take a cavalier and careless attitude to 
quality reporting from being rewarded, while those who are 
conscientious are being punished.
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Do away with Indicators then? 
No, but prune away the dead wood and apply selected 
indicators in a different way. Highly motivated professionals 
want to know if they are doing the right things and if they 
are doing them in the right way. They are challenged by 
such feedback to perform even better. Internal and external 
indicators can play an important role in this respect. As long 
as they are valid, do not overly disrupt or displace the care 
process, and as long as the professionals are given the time and 
resources to analyse them, and to understand and apply the 
resulting information to make improvements. A minimum 
of external indicators, shrewdly designed and absolutely 
reliable, can strengthen the process of internal improvement 
because they can create a sense urgency that might otherwise 
be overwhelmed by other priorities. Implementation details - 
such as in case of the four-hour A&E-target - are essential and 
should be constructed in consultation with professionals. If 
indicators are implemented in this way, the Theory X focus on 
distrust will gradually be supplanted by the Theory Y approach 
where everyone pulls their weight - ‘all hands on deck - a storm 
is brewing’. It is good to see that cooperation initiatives are on 
the increase. 
Honourable audience, our healthcare system faces many 
challenges. I am not an irredeemable optimist - quite the 
opposite. It is just that I am absolutely convinced that the good 
healthcare system of the Netherlands will not further improve, 
will not be experienced as being better and will not be viewed 
as being better, if we breed distrust and a ‘them against us’-way 
of thinking. Such a path will discourage motivated, talented 
and ambitious young people from training to be healthcare 
professionals. But you are right - I do have a positive view. And 
that is that I am convinced that we will get the best out of our 
healthcare professionals if intrinsic motivation is nurtured 
alongside an awareness of urgency, by means of the prudent 
implementation of modest external forces. My firm belief is 
that this is the way to achieve the best healthcare and to deliver 
best value for money.
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